NK-cell lymphomas and leukemias - A spectrum of tumors with variable manifestations and immunophenotype

被引:86
作者
Hasserjian, Robert P.
Harris, Nancy Lee
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
natural killer cell; T cell; lymphoma; leukemia;
D O I
10.1309/2F39NX1AL3L54WU8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Natural killer (NK) cells are lymphocytes that have some phenotypic and functional similarities to cytotoxic T cells but do not express the T-cell receptor complex. NK-cell malignancies may be localized or disseminated at initial examination, and most behave aggressively. The variable presentation of NK-cell lymphomas and leukemias suggests that they represent a spectrum Of disease, with Epstein-Barr virus (EBV) implicated in the pathogenesis of most cases. Using cases presented in Session 10 of the 2005 Society for Hematopathology/European Association for Haematopathology Workshop on T-cell and NK-cell malignancies, we discuss outstanding issues in the classification and diagnosis of NK-cell malignancies. These difficulties are related to unusual sites of manifestation, atypical immunophenotypic features, and EBV+ T-cell tumors that resemble classical extranodal NK/T-cell lymphoma, nasal-type (EN-NK/T-NT). Although some of these cases can be grouped into EN-NK/T-NT, classification of tumors that have atypical or discordant features will remain controversial, particularly when EBV is absent.
引用
收藏
页码:860 / 868
页数:9
相关论文
共 23 条
[1]  
Chan J K, 1998, Anat Pathol, V3, P77
[2]  
Chan JKC, 1996, CANCER, V77, P1198, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1198::AID-CNCR29>3.0.CO
[3]  
2-W
[4]   Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm [J].
Chan, JKC ;
Sin, VC ;
Wong, KF ;
Ng, CS ;
Tsang, WYW ;
Chan, CH ;
Cheung, MMC ;
Lau, WH .
BLOOD, 1997, 89 (12) :4501-4513
[5]  
Chan JKC, 2001, Pathology and genetics of tumours of haematopoietic and lymphoid tissues, P204
[6]   Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index [J].
Chim, CS ;
Ma, SY ;
Au, WY ;
Choy, C ;
Lie, AKW ;
Liang, R ;
Yau, CC ;
Kwong, YL .
BLOOD, 2004, 103 (01) :216-221
[7]   Sinonasal lymphoma - A clinicopathologic analysis of 58 cases from the Massachusetts General Hospital [J].
Cuadra-Garcia, I ;
Proulx, GM ;
Wu, CL ;
Wang, CC ;
Pilch, BZ ;
Harris, NL ;
Ferry, JA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (11) :1356-1369
[8]   EPSTEIN-BARR VIRUS-ASSOCIATED NATURAL-KILLER LARGE GRANULAR LYMPHOCYTE LEUKEMIA [J].
GELB, AB ;
VANDERIJN, M ;
REGULA, DP ;
CORNBLEET, JP ;
KAMEL, OW ;
HOROUPIAN, DS ;
CLEARY, ML ;
WARNKE, RA .
HUMAN PATHOLOGY, 1994, 25 (09) :953-960
[9]  
Harabuchi Y, 1996, CANCER, V77, P2137, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.3.CO
[10]  
2-N